Myerson Merle
Cardiovascular Disease Prevention Program & Lipid Clinic, Cardiology Section, Institute for Advanced Medicine (HIV), Mount Sinai St. Luke's, Mount Sinai Roosevelt, 1111 Amsterdam Avenue, New York, NY 10025, USA.
Endocrinol Metab Clin North Am. 2016 Mar;45(1):141-69. doi: 10.1016/j.ecl.2015.09.010.
The development and use of antiretroviral medications to treat patients infected with human immunodeficiency virus (HIV) has dramatically changed the course of this disease from one that was fatal to a chronic and more manageable condition. Recommendations and guidelines for the general population are presented in this review with suggestions as to how they may be applied to this patient population. Issues for which there is little or no information available are noted to highlight the many gaps in our knowledge regarding diagnosis and management of dyslipidemia for patients living with HIV.
抗逆转录病毒药物的研发及应用，用于治疗感染人类免疫缺陷病毒（HIV）的患者，极大地改变了这种疾病的进程，使其从一种致命疾病转变为一种慢性且更易控制的病症。本综述介绍了针对普通人群的建议和指南，并就如何将这些建议和指南应用于该患者群体提出了建议。文中指出了几乎没有或完全没有可用信息的问题，以突出我们在HIV感染者血脂异常诊断和管理方面的诸多知识空白。
